CMT Simplified
Welcome to CMT Simplified, brought to you by the Hereditary Neuropathy Foundation. This podcast delivers bite-sized updates on the latest research and advancements in Charcot-Marie-Tooth disease (CMT). In episodes under 20 minutes, we cut through the jargon to bring you clear, concise insights into breakthroughs, treatments, and scientific discoveries shaping the future of CMT.
Perfect for busy listeners, *CMT Simplified* is your on-the-go resource for understanding complex information in a straightforward and approachable way. Stay informed, empowered, and up-to-date—one short episode at a time!
CMT Simplified
Why HNF's CMT Summit + Retreat Matters
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Learn more at CMTsummit.org
Your laptop can give you a thousand links about Charcot-Marie-Tooth disease, but it can’t give you certainty, context, or a hand on your shoulder when the fear spikes at 2 a.m. We dig into the newly released agenda for the HF Clinical Trial Readiness Summit Plus Retreat (April 16–18, 2026 in Ellicott City, Maryland) to answer a blunt question: why show up in person when the internet is overflowing with medical information?
We walk through the rare disease clinical trial problem set that keeps CMT therapies slow and scarce: small patient populations, highly variable symptoms, rigid legacy trial designs, and the need for FDA-ready endpoints. From new regulatory thinking to the push for a unified CMT data ecosystem, we explain what “trial readiness” really means and why it’s more than slides and jargon. We also unpack how biobanks and wearable studies turn real life into usable evidence by capturing continuous gait and fatigue signals that a short clinic visit will never see.
Then we shift to the parts of living with CMT that research often misses: breathing, hearing, eyesight, sleep, and the exhausting reality of fatigue. You’ll hear why a new validated CMT fatigue assessment matters for drug approval, and why practical sessions, respiratory tools, and hands-on demos like bracing, orthotics, adaptive driving, service dogs, and everyday gadgets can replace abstract anxiety with tactile clarity. Finally, we make the case that the most powerful “intervention” might be community itself, because isolation has measurable physical costs and connection can change the baseline.
If this resonates, subscribe, share this with someone navigating CMT, and leave a review so more people can find the conversation. What’s the one tool, symptom, or question you wish researchers would take more seriously?
Thanks for listening! Learn more at hnf-cure.org and subscribe for more updates on CMT research and advancements.
So you get a diagnosis, or maybe um maybe you're managing a chronic condition that you've had for years, and the instinct is pretty much universal.
SPEAKER_00Right. You open your laptop.
SPEAKER_01Exactly. You open your laptop and you fall straight down that digital rabbit hole.
SPEAKER_00Oh, we all do it.
SPEAKER_01Yeah. You find yourself skimming these dense medical journals that frankly require a PhD to decode. You're scrolling through endless web articles and you're joining like half a dozen Facebook support groups in an hour.
SPEAKER_00And your feed just transforms into this relentless stream of information. I mean, some of it might be vaguely helpful, but a lot of it is just panic-inducing. Totally. And the net result is usually just this profound overwhelm. It creates a very modern, very specific kind of medical isolation, you know?
SPEAKER_01Aaron Ross Powell Wow. Yeah, medical isolation. That's a good way to put it.
SPEAKER_00Aaron Powell Because you're drowning in data points, but you are sitting there completely alone.
SPEAKER_01Aaron Ross Powell You are technically connected to thousands of other patients across the globe, right?
SPEAKER_00Yeah.
SPEAKER_01But your actual lived experience is just staring at a glowing rectangle in your living room.
SPEAKER_00Which is incredibly isolating.
SPEAKER_01Right. Which sets up a fascinating question for us today. In a world where we can access literally any piece of medical research, any clinical trial update, right from a supercomputer in our pockets, why would you ever pack a bag, navigate the logistics of travel, and go to a physical in-person medical event?
Why Travel To A Summit
SPEAKER_00Aaron Powell Because the Internet has um it sold us this illusion that we can be fully informed without ever leaving the house.
SPEAKER_01Yeah.
SPEAKER_00We mistake access to information for actual understanding, and more importantly, practical application.
SPEAKER_01Okay, let's unpack this because today, welcome to the deep dive. We are looking at the newly released agenda for the HF Clinical Trial Readiness Summit Plus Retreat.
SPEAKER_00An incredible event.
SPEAKER_01Truly. It's happening April 16th through the 18th, 2026, in Ellicott City, Maryland. And looking through the stack of sources we have, this particular agenda really dismantles the idea that a website or a social media group is enough.
SPEAKER_00It completely flips the script.
SPEAKER_01Yeah. We are exploring why this specific gathering fundamentally changes the paradigm for anyone living with shortcomer e-tooth disease or CMT. It's really about moving from being an isolated data consumer, just doom scrolling, to an active participant in your own care.
SPEAKER_00Aaron Powell And the mission of our deep dive today is to pull this agenda apart, right? Yeah. To look at the underlying mechanics of what they're actually building here.
SPEAKER_01Aaron Ross Powell Right. It's not just a schedule.
SPEAKER_00Aaron Ross Powell Exactly. We're not just looking at a list of speakers. We're looking at this highly engineered collision between cutting-edge, rigid scientific research, and well, the messy, tangible realities of daily life. Trevor Burrus, Jr.
SPEAKER_01The day-to-day stuff.
Fixing Rare Disease Trial Bottlenecks
SPEAKER_00Yeah. The goal is to show you how a physical environment bridges that gap in ways a screen simply cannot replicate.
SPEAKER_01So any rigorous deep dive into a medical condition, it really has to start with the data, the hard science. Aaron Powell Absolutely. And when you look at the research track for this summit, it becomes clear right away that research here doesn't mean some dry inaccessible lecture where an academic speaks at you in Latin for an hour.
SPEAKER_00Aaron Ross Powell No, not at all. They are targeting the actual structural bottlenecks of rare disease research.
SPEAKER_01Trevor Burrus Right. Like they have a session right out of the gate dedicated to the FDA's new framework for rare diseases. Trevor Burrus, Jr.
SPEAKER_00Which is huge.
SPEAKER_01And it features Janet Woodcock, the former commissioner of the FDA.
SPEAKER_00Aaron Ross Powell Yeah. Bringing in someone of Janet Woodcock's caliber alongside organizations like the Critical Path Institute, it signals a massive shift in strategy.
SPEAKER_01Aaron Ross Powell How so?
SPEAKER_00Aaron Ross Powell Well, the historical problem with rare diseases like CMT is that traditional clinical trials were designed for common ailments.
SPEAKER_01Yeah.
SPEAKER_00Things like high blood pressure or cholesterol. Trevor Burrus, Jr.
SPEAKER_01Where you can just find millions of people.
SPEAKER_00Aaron Ross Powell Exactly. You can easily recruit 10,000 patients in those cases to prove a drug works.
SPEAKER_01Aaron Powell But with a rare disease, you just don't have those numbers sitting in one convenient location.
SPEAKER_00Aaron Powell You don't. And the presentation of the disease is heterogeneous, meaning everyone's CMT looks a little bit different. Right. So traditional statistical models just fail. When the agenda talks about a new framework with former FDA leadership, they're talking about changing the actual math of how we prove a drug's efficacy. Oh wow. They are actively negotiating how to build regulatory flexibility without sacrificing safety. And honestly, that is the only way CMT trials can move at the lightning speed the community desperately needs.
Building A Unified CMT Data Ecosystem
SPEAKER_01That makes so much sense. And that structural bottleneck leads right into another massive barrier they're tackling, which is data isolation. Yeah.
SPEAKER_00The silos.
SPEAKER_01Right. There's a session on the agenda called Cracking the CMT bottlenecks, a unified data ecosystem.
SPEAKER_00Aaron Powell It's a critical session.
SPEAKER_01Let me give you an analogy for how CMT data exists right now. It's like trying to put together a thousand-piece puzzle, but the pieces are scattered across 50 different doctors' offices.
SPEAKER_00Yeah, that's exactly it.
SPEAKER_01Or like training an AI model, but every single hospital and clinic is speaking a completely different language and refusing to share their servers. The algorithms can't spot the patterns because the data is siloed.
SPEAKER_00It's all locked away.
SPEAKER_01Right. So this unified data ecosystem is the process of finally forcing everyone onto the same operating system, right? Sweeping all those puzzle pieces onto one table so researchers can finally query the entire global landscape of CMT at once.
Biobank And Wearables As Real Research
SPEAKER_00And without that unified server, breakthroughs just stall in the lab. But what's fascinating here is that you, as an attendee, are not just sitting in a folding chair hearing about this theoretical ecosystem.
SPEAKER_01You're actually part of it.
SPEAKER_00Exactly. The agenda integrates real-time scientific contribution into the event itself. Right outside the lecture halls, they're running an open CMT biobank.
SPEAKER_01Yeah, and a wearable study too, right?
SPEAKER_00Yes, running throughout the entire weekend.
SPEAKER_01I was actually looking into that wearable study component. It is fundamentally different from, you know, just closing the rings on your Apple Watch or tracking your daily steps.
SPEAKER_00Oh, entirely different. It's capturing high fidelity, continuous data.
SPEAKER_01Because normally a neurologist only sees a patient for what, 15 minutes every six months?
SPEAKER_00If that, yeah.
SPEAKER_01Right. They ask you to walk down a brightly lit hallway and they make a quick visual assessment.
SPEAKER_00Which misses so much. But a clinical wearable study, it tracks microgate variations over, say, 72 hours. Wow. It captures how your stride changes when you're fatigued at 8 p.m., or how your balance shifts when you navigate uneven pavement outside.
SPEAKER_01Stuff the doctor never sees.
SPEAKER_00Exactly. That granular data is exactly what pharmaceutical companies need to prove their interventions are actually altering the course of the disease.
SPEAKER_01So by simply walking around the summit wearing one of these devices, you are generating the exact data points the scientists on stage are begging for.
SPEAKER_00You're moving the needle on research just by grabbing a cup of coffee.
SPEAKER_01You're actively training that AI model we just talked about just by being in the room.
SPEAKER_00Yeah.
Hidden Symptoms Beyond Mobility
SPEAKER_01Which is incredible. But that naturally shifts our focus, I think, from how scientists are gathering data for the future to how you navigate the reality of your symptoms today.
SPEAKER_00Right, because the research is vital.
SPEAKER_01But you still have to wake up and live your life tomorrow morning.
SPEAKER_00Precisely. And this is where the clinical side and the practical side of the agenda beautifully intersect. It addresses what the scientific community calls hidden outcomes.
SPEAKER_01Aaron Ross Powell Hidden Ocomes. Yeah, there is a major session on the schedule focusing on breathing, hearing, and eyesight in CMT.
SPEAKER_00Aaron Powell Which is so often overlooked.
SPEAKER_01It's incredibly illuminating because almost all the mainstream literature you read on Charcot Marie 2 focuses on mobility. It's all about the peripheral nerves reaching down to the toes and the fingers, causing, you know, foot drop or grip issues. Right. But the auditory nerve is also a nerve. The phrenic nerve, which controls your diaphragm and your ability to take a deep breath, is also vulnerable to that same myelin or exonal degradation.
SPEAKER_00And those hidden outcomes, they dictate your quality of life just as heavily as mobility issues do.
SPEAKER_01Absolutely.
SPEAKER_00But they get completely overshadowed in clinical settings. Researchers are bringing this up at the summit because they need to figure out how to capture and measure these invisible symptoms during a drug trial.
Measuring Fatigue So Drugs Count
SPEAKER_01Okay. Speaking of measuring invisible symptoms, I actually need to push back on a specific item in this agenda.
SPEAKER_00Oh, okay, let's hear it.
SPEAKER_01There is an entire session dedicated to a new CMT fatigue assessment developed by researchers from the University of Sydney.
SPEAKER_00Yes.
SPEAKER_01On the surface, I gotta say, this sounds incredibly bureaucratic. Like, isn't fatigue just fatigue? If a patient is tired, they're tired. Why do we need a whole new scientific assessment, an entire presentation just for being tired?
SPEAKER_00I get that. It sounds like academic overkill, right?
SPEAKER_01A little bit, yeah.
SPEAKER_00Until you view it through the lens of the FTA. In the realm of clinical trials, if you cannot objectively measure a symptom, you cannot legally treat it.
SPEAKER_01Wait, really? So if a patient takes an experimental drug and tells the researcher, hey, I feel vastly more energetic today, the FTA does not accept that as proof.
SPEAKER_00They absolutely cannot accept it because fatigue is notoriously subjective.
SPEAKER_01Oh, I see.
SPEAKER_00Right. An exhausting day for one person might feel like a baseline Tuesday for someone else.
SPEAKER_01Fair point.
SPEAKER_00So if a pharmaceutical company develops a compound that miraculously cures the severe fatigue associated with CMT, but they have no standardized, scientifically validated metric to prove that shift to a regulatory body.
SPEAKER_01The drug just doesn't get approved.
SPEAKER_00The drug is dead in the water. It will never reach the market.
SPEAKER_01Oh wow. So this new CMT fatigue assessment, they're essentially inventing the ruler.
SPEAKER_00Yes.
SPEAKER_01They're designing the instrument so they can finally measure the result.
SPEAKER_00Exactly. They are creating a validated secondary endpoint. It bridges this massive gap between the subjective exhaustion a patient feels in their living room and the objective data the FDA requires for drug approval.
SPEAKER_01That is fascinating.
Practical Tools For Sleep And Breathing
SPEAKER_00And what makes this agenda so compelling is how it pairs that high-level research with immediate practical application.
SPEAKER_01Right, the patient track.
SPEAKER_00Yeah. While the scientists are discussing how to measure fatigue, the summit is running that parallel patient track. You can walk out of the fatigue assessment presentation and walk straight into a session called CMT and Sleep.
SPEAKER_01Where you learn actual tools.
SPEAKER_00Actionable, immediate tools to handle that exhaustion tonight. They offer sessions on adaptive respiratory wellness exercises, which connects right back to those hidden breathing outcomes we mentioned.
SPEAKER_01So the summit provides the daily life hacks to manage the exact problems the researchers down the hall are trying to cure.
SPEAKER_00It's a closed loop of support.
SPEAKER_01And the proximity of those two things, the theoretical science and the immediate physical solution, I think that brings us to the most tangible advantage of attending the summit in person.
SPEAKER_00Absolutely.
SPEAKER_01Because look, you can read a medical journal about fatigue online, you can read an article about respiratory exercises, but the physical reality of a motor neuropathy condition requires physical hands-on solutions.
SPEAKER_00You can't touch a physical solution through a zoom screen.
SPEAKER_01Exactly. Tactile clarity is impossible to achieve digitally. When your physical body is changing, you need to physically interact with the tools designed to assist it.
SPEAKER_00If we connect this to the bigger picture, it's about removing the fear of the unknown.
SPEAKER_01Yeah, let's look at the interactive demos they've engineered for this weekend. They have a live bracing demo and an orthotic innovations panel featuring top prosthetists.
SPEAKER_00Incredible resource.
SPEAKER_01They have an adaptive driving and vehicle demo where you can physically explore what's involved in transitioning to hand controls. And there's a session called CMT Pausabilities, which explains how specially trained service dogs support life with CMT.
SPEAKER_00Consider the mechanics of adaptive driving for a second. Transitioning to hand controls is a profound psychological hurdle for many patients.
SPEAKER_01I can imagine.
SPEAKER_00It often signifies a loss of independence or a departure from what they consider normal. And just reading about hand controls on a forum, that just leaves you with abstract anxiety.
Community As The Strongest Intervention
SPEAKER_01Right. I was actually researching how these controls work before we sat down. You are essentially bypassing the need for ankle dorsiflexion, the ability to lift your foot, which is often lost in CMT. Right. And you're translating that required breaking and accelerating power into a lever system that utilizes shoulder and tricep leverage. Which sounds complicated when you just say it out loud. Exactly. Trying to visualize that geometry from a PDF is incredibly difficult. But standing in a parking lot, physically gripping the lever, pushing it forward to feel the resistance of the brake line.
SPEAKER_00It demystifies the entire process.
SPEAKER_01It really does. Reading about an adaptive vehicle online is like reading a recipe, but getting to sit in one and see it demoed in person is like finally tasting the meal.
SPEAKER_00And I love that analogy. The fear dissipates when the abstract concept becomes a tangible piece of metal in your hand. It stops being a symbol of disease progression and simply becomes a tool. Yeah. And the same applies to the service dog session. A service dog for CMT isn't just a companion, you know, they are trained for mobility and balance assistance.
SPEAKER_01Right. They do actual physical labor.
SPEAKER_00Exactly. They wear these specialized rigid harnesses. When a patient experiences a draw foot stumble, the dog is trained to brace and provide a counterweight to interrupt the momentum of the fall.
SPEAKER_01Wow, that's amazing.
SPEAKER_00But you have to see that kinetic interaction in person to truly understand how it changes a person's ability to navigate the world safely.
SPEAKER_01And the friction of accessing these physical solutions is completely removed at this event. The agenda literally lists open surgery embracing consults running concurrently with the main sessions.
SPEAKER_00Yes.
SPEAKER_01Plus a live surgery QA with Dr. Pfeffer, who is a leading expert in the field. Think about the psychological barrier and the sheer logistical nightmare of getting an appointment with a top-tier specialist. Months, you travel to a sterile hospital, you sit in a fluorescent-lit waiting room, and your blood pressure spikes before you even see the doctor. Here, those same experts are just standing down the hall, available for a casual conversation. You're stripping away the clinical intimidation factor entirely.
SPEAKER_00It shifts the power dynamic. In a hospital, you are on their turf. At this summit, the specialists are on your turf.
SPEAKER_01Which is perfectly captured by this one session called CMT Everyday Hacks, Gadgets, and Helpful Tools. Demo and share and tell.
SPEAKER_00I love that one.
SPEAKER_01Attendees are encouraged to bring their own adaptive gadgets to share. You get to feel the weight of a specialized utensil, or test the grip of a button hook, or see how someone else modified their shoes.
SPEAKER_00That level of physical clarity and that immediate application is something the internet will never be able to provide. It empowers the individual.
SPEAKER_01It really does.
SPEAKER_00It moves you from feeling like a passive victim of your symptoms to an active, equipped manager of your environment.
SPEAKER_01So we've dissected the cutting-edge FDA frameworks, the data ecosystems, and the physical tools like braces and hand controls. But looking at the overall architecture of this agenda, it's undeniable that the most powerful intervention at this summit isn't a piece of technology.
SPEAKER_00No, it isn't.
SPEAKER_01It's the person sitting next to you.
SPEAKER_00Aaron Powell The Community Integration. This is the plus retreat portion of the summit plus retreat title. And honestly, it is arguably the most vital component for long-term health outcomes.
SPEAKER_01A massive part of understanding this event is understanding the DNA of the organizers. The Hereditary Neuropathy Foundation, or HF, is run by patients for patients.
SPEAKER_00Which changes everything.
SPEAKER_01Right. Allison Moore, the founder and CEO, Estella Lugo, the program development manager, they live with CMT, and that lived experience dictates the pacing, the lighting, and the structure of the entire weekend. It's palpable. This isn't a heavy, sterile medical conference where doctors talk about patients in the third person.
SPEAKER_00Exactly. When organizers have the condition themselves, they anticipate the hidden frictions.
SPEAKER_01Like what?
SPEAKER_00Well, a doctor organizing a conference might schedule a three-hour standing mixer without a second thought, right?
SPEAKER_01Oh yeah, true.
Designing For Patients And Caregivers
SPEAKER_00But a patient organizer creates seated breakout sessions and builds in adequate transition times between rooms. You see this deep empathy reflected in the highly curated breakout circles they have.
SPEAKER_01The breakout groups look amazing.
SPEAKER_00They've designed intimate spaces for very specific shared experiences: a men's group, a women's health circle, teen journaling, parenting support, and a dedicated group for care partners and spouses.
SPEAKER_01That caregiver support is so, so crucial. But let me play devil's advocate for a second.
SPEAKER_00Go for it.
SPEAKER_01We just spent 20 minutes discussing groundbreaking FDA pathways, biobanks, and unified AI data ecosystems. Amidst all of that rigorous science, there is a session on the agenda called CMT speedfriending.
SPEAKER_00There is, yeah.
SPEAKER_01It sounds a bit like a cruise ship activity. Is something that casual really necessary at a high-level medical summit?
SPEAKER_00It is entirely necessary. Because, as we touched on earlier, isolation is a comorbidity.
SPEAKER_01Right.
SPEAKER_00The psychological burden of a rare disease can be just as damaging as the physical neurodegeneration. When you feel entirely alone in your experience, your body remains in a heightened state of stress.
SPEAKER_01Which affects you physically.
SPEAKER_00Absolutely. Chronic stress elevates cortisol levels, which drives inflammation, which can observably worsen neurological symptoms. Isolation has a measurable physiological impact.
SPEAKER_01So the speed friending isn't just an icebreaker, it's an actual clinical intervention.
SPEAKER_00Precisely. When you live with a rare condition, you spend your entire life explaining your existence to the outside world.
SPEAKER_01Always educating the people around you.
SPEAKER_00Right. You explain why you walk with an altered gate, why you ask for jars to be opened, why you have to cancel plans due to sudden fatigue. That constant explanation is exhausting.
SPEAKER_01I can only imagine.
SPEAKER_00So meeting a room full of people who just get it, where you don't have to say a single word of justification, it fast tracks a profound sense of psychological relief. It lowers the baseline stress.
SPEAKER_01Wow.
SPEAKER_00And the friendships formed in those spaces become the safety net that catches you when you face a difficult progression three years down the line.
SPEAKER_01The agenda even explicitly says leave with new friends who just get it. It's written right into their goals. And you can see how they intentionally engineered the weekend to be uplifting rather than heavy.
SPEAKER_00Definitely.
Ending With Joy And A New Model
SPEAKER_01Friday night features outdoor fire pits and a sunset social hour, followed by a CMT movie night. They have a youth lounge, a kids' activity table, and a live CMT story time reading featuring children's authors.
SPEAKER_00Which is so important for the kids. Normalizing the condition for the next generation changes their entire trajectory. It shows a child with CMT that they are not an anomaly. They're part of a vibrant active community.
SPEAKER_01Yeah. And they even incorporate movement in a way that eliminates the usual anxiety around exercise.
SPEAKER_00Okay, adaptive fitness.
SPEAKER_01They have fully seated yoga designed specifically with CMT biomechanics in mind. They have balance exercises and seated aerobics. But honestly, the most brilliant structural choice on this entire agenda is how they close out the event on Saturday evening.
SPEAKER_00Oh, the fashion show.
SPEAKER_01Yes. They host a grand finale adaptive fashion show and raffles.
SPEAKER_00It's a masterclass in reframing a friction point.
SPEAKER_01Totally. Because finding clothes or shoes that fit over bulky ankle foot orthotics or dealing with buttons when you have limited hand dexterity, that is a daily source of deep frustration for so many people.
SPEAKER_00It's a constant struggle.
SPEAKER_01But the summit takes that exact point of friction and turns it into a runaway celebration of self-expression and CMT-friendly clothing. That is the moment you realize this is not just a medical conference. It's a homecoming.
SPEAKER_00It addresses the complete human being. You spend your morning absorbing complex genetic trial protocols, and you spend your evening cheering on your new friends as they model adaptive footwear on a runway.
SPEAKER_01So, what does this all mean? When you zoom out and look at the totality of the CMT 26 Summit, you see a model that completely rewrites how we handle medical information.
SPEAKER_00It really does.
SPEAKER_01It takes the rigorous, lightning speed research of a top-tier clinical conference and wraps it entirely in the warmth, the joy, and the fiercely practical support of a community retreat. You aren't just absorbing data, you're consulting directly with surgeons, you are physically testing adaptive technology, and you're building a resilient network.
SPEAKER_00You're finally stepping out of the digital rabbit hole, closing the laptop, and stepping into a room full of tangible answers.
How Patient Expertise Speeds Cures
SPEAKER_01If you or someone you love is impacted by Charcot-Merie tooth disease, this represents a fundamental shift in how you manage the condition. You can view the full, highly detailed agenda, read about the experts we discussed, and secure your tickets by registering at cmtsummit.org.
SPEAKER_00Highly recommend checking it out.
SPEAKER_01Again, that is cmtsummit.org for the April 16th through 18th event in Ellicott City, Maryland. It is an investment in understanding exactly how to navigate whatever comes next.
SPEAKER_00It certainly redefines the boundaries of patient advocacy and you know it leaves you with a really compelling thought to explore on your own.
SPEAKER_01What's that?
SPEAKER_00Well, we've discussed data silos and rigid FDA frameworks at length today. But consider the long term impact of this specific environment. When the medical establishment stops viewing patients merely as passive subjects to be studied and finally starts integrating them as the foremost experts of their own lived experience, how much faster does the past to a cure actually become?